BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 682233)

  • 1. [Effect of hemofiltration on plasma levels of parathyroid hormone and calcitonin].
    De Fremont JF; Fournier A; Gueris J; Caillens C; Coevoet B; Lambrey G; Quichaud J
    J Urol Nephrol (Paris); 1978; 84(4-5):323-8. PubMed ID: 682233
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of calcium infusion on calcitonin and parathyroid hormone concentrations in normal and hemodialyzed subjects.
    Isaac R; Nivez MP; Piamba G; Fillastre JP; Ardaillou R
    Clin Nephrol; 1975 Jan; 3(1):14-7. PubMed ID: 1126058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parathyrin and calcitonin in patients with chronic renal insufficiency].
    Dzhavad-Zade MD; Agaev MM; Karaev ME
    Med Radiol (Mosk); 1985 Dec; 30(12):47-9. PubMed ID: 4079692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone, calcium and phosphate balance in hemofiltration.
    Fuchs C; Doht B; Dorn D; McIntosh C; Ritter D; Scheler F
    J Dial; 1977; 1(6):631-40. PubMed ID: 608872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma calcitonin in renal osteodystrophy.
    Chittal SM; Oreopoulos DG; DeVeber GA; Thomas P; Rabinovich S; Lloyd GJ; Kumar MA; Rapoport A
    Can Med Assoc J; 1971 Jun; 104(12):1098-100. PubMed ID: 4931771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD.
    Martínez ME; Miguel JL; Gómez P; Selgas R; Salinas M; Gentil M; Mateos F; Montero JL; Sánchez Sicilia L
    Clin Nephrol; 1983 May; 19(5):250-3. PubMed ID: 6851265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis.
    Pabico RC; Rivero AJ; McKenna BA; Freeman RB
    Proc Eur Dial Transplant Assoc; 1983; 19():221-6. PubMed ID: 6878235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cimetidine and circulating calciotropic hormone levels in uremic patients: evidence for a suppressive effect on calcitonin secretion.
    Sebert JL; Decourcelles PH; Morinière P; Calmette C; Gueris J; Makdassi R; Khassouf J; Andrejak M; Fournier A
    Miner Electrolyte Metab; 1982 Dec; 8(6):293-9. PubMed ID: 7167135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diurnal changes in the levels of immunoreactive parathyroid hormone and calcitonin in patients with chronic renal insufficiency].
    Ivić MA; Bogićević M; Djordjević V; Mitić M; Stefanović V
    Srp Arh Celok Lek; 1992; 120(5-6):141-5. PubMed ID: 1465667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastric acid secretion and calcium metabolism in patients with chronic hemodialysis].
    Fendler JP; Khazine F; Dongradi G; Cassan P; Beaugrand M; Salmon D
    J Urol Nephrol (Paris); 1978 Sep; 84(9):658-63. PubMed ID: 748587
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium and phosphorus metabolism in maintenance hemodialysis.
    Ritz E; Mehls O; Krempien B
    Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of lowering the serum phosphate on parathyroid hormone secretion and total serum calcium during regular hemodialysis.
    Hill AV; Thein-Than ; Cook DB; Derr KN; Latner AL
    Clin Nephrol; 1973; 1(5):284-9. PubMed ID: 4797465
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].
    Novikov AI
    Ter Arkh; 1997; 69(12):63-7. PubMed ID: 9503540
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcitonin in chronic renal failure.
    Garancini S; Ballada L; Roncari G; Gastaldi L
    Nephron; 1983; 34(4):224-7. PubMed ID: 6877457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive parathyroid hormone and calcitonin in plasma and ultrafiltrate before and after haemodialysis.
    Fauchald P; Gautvik VT; Gautvik KM
    Scand J Clin Lab Invest; 1985 May; 45(3):229-35. PubMed ID: 4001828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parathormone and calcitonin in the blood in chronic kidney diseases].
    Mosin VM; Iagoda AV; Salanda BS; Derevianko NA
    Ter Arkh; 1982; 54(7):82-4. PubMed ID: 7135230
    [No Abstract]   [Full Text] [Related]  

  • 17. Mineral metabolism during a hemofiltration session in children.
    Bianchi ML; Bettinelli A; Soldati L; Saccaggi A; Ortolani S; Edefonti A
    Int J Artif Organs; 1986 Jul; 9(4):257-62. PubMed ID: 3781652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phosphorus and calcium metabolism and its hormonal regulation in chronic kidney failure].
    Nikiforova NV; Strunin SE; Ermolenko VM; Mozzhechkov VT; Khomiakova VN
    Ter Arkh; 1985; 57(1):103-7. PubMed ID: 3983831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dialysate calcium concentration on plasma parathyroid hormone during hemodialysis.
    McIntosh CH; Fuchs C; Dorn D; Quellhorst E; Henning HV; Hesch RD; Scheler F
    Nephron; 1977; 19(2):88-94. PubMed ID: 887190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.